Structural basis for the asymmetric binding of coactivator SRC1 to FXR-RXRα and allosteric communication within the complex
Farnesoid X receptor (FXR) is a promising target for treatment of metabolic associated fatty liver disease (MAFLD). In this study, we employed an i…
